CD4 and neoplasm: CD4+ T cells contribute to the immune system’s ability to combat tumor progression through their differentiation into various subtypes, such as Th1, Th2, Th17, and regulatory T cells (Tregs), among others, each with distinct cytokine expression profiles and immune-modulatory functions [38].